Maria R Alvarez-Lopez
Overview
Explore the profile of Maria R Alvarez-Lopez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Legaz I, Bolarin J, Campillo J, Moya-Quiles M, Miras M, Muro M, et al.
Int J Mol Sci
. 2022 Oct;
23(20).
PMID: 36293011
Chronic liver rejection (CR) represents a complex clinical situation because many patients do not respond to increased immunosuppression. Killer cell immunoglobulin-like receptors/Class I Human Leukocyte Antigens (KIR/HLA-I) interactions allow for...
2.
KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling
Gimeno L, Serrano-Lopez E, Campillo J, Canovas-Zapata M, Acuna O, Garcia-Cozar F, et al.
Cancers (Basel)
. 2020 Oct;
12(10).
PMID: 33076479
Killer-cell immunoglobulin-like receptors (KIR) are expressed by natural killer (NK) and effector T cells. Although KIR+ T cells accumulate in oncologic patients, their role in cancer immune response remains elusive....
3.
Martinez-Sanchez M, Periago A, Legaz I, Gimeno L, Mrowiec A, Montes-Barqueros N, et al.
Oncoimmunology
. 2016 May;
5(4):e1093721.
PMID: 27141379
Missing self recognition makes cancer sensitive to natural killer cell (NKc) reactivity. However, this model disregards the NKc licensing effect, which highly increases NKc reactivity through interactions of inhibitory killer...
4.
Boix F, Llorente S, Mrowiec A, Eguia J, Lopez-Hernandez R, Bernardo M, et al.
Urol J
. 2014 Jul;
11(3):1695-8.
PMID: 25015619
No abstract available.
5.
Bosch A, Llorente S, Eguia J, Mrowiec A, Boix F, Lopez-Hernandez R, et al.
Hum Immunol
. 2014 Feb;
75(4):338-41.
PMID: 24486575
We report an interesting case concerning an irreversible antibody-mediated rejection (AMR), associated with anti-HLA-C DSA, which occurred after a second kidney transplantation despite having determined a low number of antibodies...
6.
Legaz I, Lopez-Alvarez M, Campillo J, Moya-Quiles M, Bolarin J, de la Pena J, et al.
Transplantation
. 2013 Mar;
95(8):1037-44.
PMID: 23478359
Background: Killer immunoglobulin-like receptors (KIRs) bind human leukocyte antigen (HLA) class-I (HLA-I) ligands and regulate functions of natural killer cells and subsets of T cells. KIR/HLA-I interactions allow predicting natural...
7.
Bosch A, Llorente S, Diaz J, Salgado G, Lopez M, Boix F, et al.
Hum Immunol
. 2012 Mar;
73(5):522-5.
PMID: 22425738
Human leukocyte antigen (HLA) antibodies are usually "epitope" and not "antigen" specific. This work presents an interesting case concerning Luminex median fluorescence intensity (MFI) levels in antibodies considered low risk...
8.
Muro M, Lopez-Alvarez M, Campillo J, Marin L, Moya-Quiles M, Bolarin J, et al.
Transpl Immunol
. 2011 Dec;
26(2-3):88-93.
PMID: 22129495
The influence of HLA matching on liver transplant is still controversial, as studies have failed to demonstrate an adverse effect of HLA mismatching on transplant outcome. We examined the effect...
9.
Muro M, Gonzalez-Soriano M, Salgado G, Lopez R, Boix F, Lopez M, et al.
Hum Immunol
. 2010 Jun;
71(9):857-60.
PMID: 20510320
Human leukocyte antigen (HLA) antibodies are epitope specific and not antigen specific. This work presents a case of intra-allele (IA) sensitization. A 40-year-old-man underwent transplantion with identical "broad" DR. He...
10.
Lopez-Alvarez M, Moya-Quiles M, Minguela A, Gil J, Miras M, Campillo J, et al.
Transplantation
. 2009 Aug;
88(3 Suppl):S54-61.
PMID: 19667963
Background: Fully human leukocyte antigens (HLA)-mismatched liver grafts are well accepted, but the HLA influence on acceptance or rejection is unclear and much less so the impact of HLA-C, which...